GOSS (Gossamer Bio) OCF Margin %: -228.38% (As of Mar. 2026)


GOSS Gossamer Bio Inc GOSS
16 GF Score
Price $0.17
! 5 Warning Signs
View Full Analysis

What is Gossamer Bio OCF Margin %?

Gossamer Bio GOSS -2.65% 16 OCF Margin % is -228.38% as of Mar. 2026. GuruFocus rates GOSS with a GF Score™ of 16/100. The stock has 5 warning signs investors should review. Among 959 Biotechnology companies, Gossamer Bio ranks worse than 66.42% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Gossamer Bio's Cash Flow from Operations for the three months ended in Mar. 2026 was $-38.72 Mil. Gossamer Bio's Revenue for the three months ended in Mar. 2026 was $16.96 Mil. Therefore, Gossamer Bio's OCF Margin % for the quarter that ended in Mar. 2026 was -228.38%.

As of today, Gossamer Bio's current OCF Yield % is -206.09%.

The historical rank and industry rank for Gossamer Bio's OCF Margin % or its related term are showing as below:

GOSS' s OCF Margin % Range Over the Past 10 Years
Min: -353.34   Med: -178.18   Max: -3.02
Current: -306.58

During the past 10 years, the highest OCF Margin % of Gossamer Bio was -3.02%. The lowest was -353.34%. And the median was -178.18%.

GOSS's OCF Margin % is ranked worse than
66.42% of 959 companies
in the Biotechnology industry
Industry Median: -66.52 vs GOSS: -306.58

Gossamer Bio OCF Margin % Related Terms

Gossamer Bio OCF Margin % Historical Data

* Premium members only.

The historical data trend for Gossamer Bio's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gossamer Bio OCF Margin % Chart

Gossamer Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -3.02 -353.34

Gossamer Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -401.70 -409.62 -272.06 -350.13 -228.38

GOSS vs TIL, ATYR, HYPD: OCF Margin % Comparison

For the Biotechnology subindustry, Gossamer Bio's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gossamer Bio OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gossamer Bio's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Gossamer Bio's OCF Margin % falls into.


GOSS
16GF Score
Gossamer Bio Inc GOSS
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gossamer Bio OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Gossamer Bio's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-171.266/48.471
=-353.34 %

Gossamer Bio's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-38.721/16.955
=-228.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -228.38% mean?
Gossamer Bio (GOSS) has a OCF Margin % of -228.38% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Gossamer Bio and its competitors. According to the industry distribution chart, Gossamer Bio ranks #637 out of 959 companies in the Biotechnology industry, placing it in the top 66.4%.
Is Gossamer Bio's OCF Margin % too high?
Gossamer Bio's current OCF Margin % is -228.38%. Based on the distribution chart, Gossamer Bio ranks #637 out of 959 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Gossamer Bio has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Gossamer Bio's OCF Margin % compare to TIL and ATYR?
According to the Biotechnology industry distribution chart, Gossamer Bio ranks #637 out of 959 companies for OCF Margin %. This places Gossamer Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Gossamer Bio and its competitors. Gossamer Bio's current OCF Margin % is -228.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gossamer Bio stock overvalued right now?
Gossamer Bio (GOSS) has a current OCF Margin % of -228.38%. The current OCF Margin % is -228.38%. Gossamer Bio's overall GF Score™ is 16/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Gossamer Bio (GOSS), the current OCF Margin % is -228.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gossamer Bio Business Description

Other Exchanges 4GB:Germany
Address 3115 Merryfield Row, Suite 120, San Diego, CA, USA, 92121
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
16GF Score

Get the complete analysis for GOSS

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.17
Price